Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy

Table 2 Angiographic and procedural characteristics

Angiographic feature/procedural characteristic	n (%)
Number of diseased vessels
Single vessel	310 (41.89)
Double vessel	276 (37.29)
Triple vessel	154 (20.81)
Patients having LMCA disease	37 (5.0)
Primary PCI	90 (12.16)
Post-procedure TIMI 3 flow	738 (99.7)
Lesion characteristics
Total number of lesions	1372
Total number of lesions treated with NeoHexa	911
Total number of lesions treated with other stents	118
Total number of lesions managed medically	343
Lesion location (for lesions treated with NeoHexa stent)
LAD	385 (42.26)
LCX	228 (25.03)
RCA	274 (30.07)
Others	24 (2.63)
Procedural characteristics
Total number of NeoHexa deployed	1317
Total number of other stents deployed	176
Lesion per patient	1.85 ± 1.06
Study stents deployed per patient	1.77 ± 1.1
Average length of study device, mm	21.90 ± 9.27
Average diameter of study device, mm	2.90 ± 0.42

LMCA: Left main coronary artery; PCI: Percutaneous coronary intervention; TIMI: Thrombolysis in myocardial infarction; LAD: Left anterior descending artery; LCX: Left circumflex artery; RCA: Right coronary artery.